PTPH1 can also dephosphorylate EGFR in breast cancer cells and disrupt EGFR interaction with ER in the cytoplasmic membrane and thereby sensitize breast cancer cells to EGFR inhibitor lapatinib [52]. This evidence concerns the gene ESR1 and breast cancer.